Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K study

BACKGROUND: There have only been a few reports about use of dipeptidyl peptidase 4 (DPP-4) inhibitors in elderly patients with type 2 diabetes mellitus (T2DM), suggesting that the safety of these agents has not been sufficiently demonstrated. We performed a comparative review of the efficacy and saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Umezawa, Shinichi, Kubota, Akira, Maeda, Hajime, Kanamori, Akira, Matoba, Kiyokazu, Jin, Yasuyuki, Minagawa, Fuyuki, Obana, Mitsuo, Iemitsu, Kotaro, Ito, Shogo, Amamiya, Hikaru, Kaneshiro, Mizuki, Takai, Masahiko, Kaneshige, Hideaki, Hoshino, Kazuhiko, Ishikawa, Masashi, Minami, Nobuaki, Takuma, Tetsuro, Sasai, Nobuo, Aoyagi, Sachio, Kawata, Takehiro, Mokubo, Atsuko, Miyairi, Yukiko, Takeda, Hiroshi, Honda, Shin, Machimura, Hideo, Motomiya, Tetsuya, Waseda, Manabu, Naka, Yoshikazu, Tanaka, Yasushi, Terauchi, Yasuo, Matsuba, Ikuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490678/
https://www.ncbi.nlm.nih.gov/pubmed/26137940
http://dx.doi.org/10.1186/s12902-015-0033-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490678/
https://www.ncbi.nlm.nih.gov/pubmed/26137940
http://dx.doi.org/10.1186/s12902-015-0033-2

Ejemplares similares